Skip to main content

Find Clinical Trials

Home
Conditions
Immune Checkpoint Inhibitor-Induced Dermatitis

Clinical trial condition

Immune Checkpoint Inhibitor-Induced Dermatitis

Explore clinical trials studying Immune Checkpoint Inhibitor-Induced Dermatitis. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Immune Checkpoint Inhibitor-Induced Dermatitis trial results

Not yet recruiting

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

NCT07530224

Conditions: Immune Checkpoint Inhibitor-Induced Dermatitis
Locations: Quzhou people's hospital Quzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

NCT07088081

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
Locations: Ain Shams University Cairo, Abbasya, Egypt

View Trial Details

Completed

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

NCT06522048

Conditions: Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +17 more
Locations: First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details